These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Growth hormone responses to graded doses of apomorphine HCl in schizophrenia.
    Author: Cleghorn JM, Brown GM, Brown PJ, Kaplan RD, Mitton J.
    Journal: Biol Psychiatry; 1983 Aug; 18(8):875-85. PubMed ID: 6137249.
    Abstract:
    Growth hormone (GH) responses to graded doses of apomorphine HCl (APO) were established in 14 normal males, ages 18-50, and 10 drug-free schizophrenic (SCZ) subjects; 99% confidence intervals were calculated for normal subjects' GH responses to graded doses of APO. Patients' GH peak levels were found to be outside the interval only when they had positive symptoms of psychosis. When they are actively psychotic, the schizophrenics' GH response to small doses of APO is more sensitive than that of normals.
    [Abstract] [Full Text] [Related] [New Search]